| 25 May 2026 |
Telmisartan |
8.1 |
20mg |
19.8mg |
-0.9% |
98.58% |
Lab B |
| 24 May 2026 |
Clomid |
8.4 |
25mg |
21.9mg |
-12.3% |
97.46% |
Lab A |
| 24 May 2026 |
Testosterone Cypionate Raw |
8.9 |
5g |
4.4g |
-12.4% |
95.03% |
Lab B |
| 24 May 2026 |
BPC-157 |
|
7.2 |
10mg |
10.7mg |
+7.0% |
BP202512 |
| 24 May 2026 |
TB-500 |
Thymosin Beta-4 |
7.1 |
10mg |
10.7mg |
+7.0% |
TB202601 |
| 24 May 2026 |
5-amino-1MQ |
7.6 |
2mg |
2.3mg |
+12.8% |
96.18% |
Lab A |
| 24 May 2026 |
Andarine (S-4) Raw |
7.2 |
100g |
89.3g |
-10.7% |
97.71% |
Lab A |
| 24 May 2026 |
EPO |
10.0 |
5mg |
4.4mg |
-12.8% |
96.46% |
Lab F |
| 24 May 2026 |
Ivermectin |
9.8 |
100mg |
118.2mg |
+18.2% |
98.99% |
Lab B |
| 24 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
8.7 |
100g |
90.8g |
-9.2% |
99.96% |
Lab E |
| 24 May 2026 |
PTD-DBM |
9.1 |
30mg |
31.5mg |
+5.0% |
99.26% |
Lab B |
| 24 May 2026 |
Minoxidil Oral |
8.0 |
100mg |
90.1mg |
-9.9% |
98.98% |
Lab F |
| 24 May 2026 |
Minoxidil Oral |
6.8 |
100mg |
101.7mg |
+1.7% |
96.68% |
Lab G |
| 24 May 2026 |
Testosterone Cypionate Raw |
8.6 |
5g |
4.9g |
-2.9% |
95.33% |
Lab B |
| 24 May 2026 |
Retatrutide |
|
9.3 |
24mg |
22.3mg |
-7.1% |
RT202602 |
| 24 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
8.3 |
200mg/ml |
200.1mg/ml |
+0.1% |
97.51% |
Lab G |
| 24 May 2026 |
BPC157 5mg + TB500 5mg Blend |
10.0 |
10mg |
10.9mg |
+8.8% |
95.29% |
Lab D |
| 24 May 2026 |
Cerebrolysin |
7.1 |
10mg |
9.3mg |
-7.2% |
95.65% |
Lab B |
| 24 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
8.0 |
50mg |
42.9mg |
-14.2% |
97.43% |
Lab B |
| 24 May 2026 |
Retatrutide |
|
6.7 |
30mg |
23.9mg |
-20.3% |
RP260130 |
| 24 May 2026 |
KPV |
6.2 |
15mg |
12.8mg |
-14.9% |
99.45% |
Lab C |
| 24 May 2026 |
NAD+ |
8.4 |
50mg |
53.3mg |
+6.6% |
96.80% |
Lab G |
| 24 May 2026 |
NAD+ |
8.6 |
15mg |
13.6mg |
-9.0% |
96.95% |
Lab F |
| 24 May 2026 |
Primobolan Oral (Methenolone Acetate) |
7.3 |
20mg |
23.8mg |
+18.8% |
99.11% |
Lab G |
| 24 May 2026 |
Tadalafil Raw |
9.7 |
100g |
106.7g |
+6.7% |
95.51% |
Lab A |
| 23 May 2026 |
Clenbuterol |
7.3 |
20mg |
21.4mg |
+6.8% |
96.65% |
Lab G |
| 23 May 2026 |
Lipo-C FAT BLASTER |
6.3 |
300mg/ml |
356.8mg/ml |
+18.9% |
95.88% |
Lab E |
| 23 May 2026 |
Cabergoline |
8.6 |
20mg |
18.0mg |
-10.2% |
99.48% |
Lab B |
| 23 May 2026 |
DNP |
8.3 |
25mg |
26.8mg |
+7.3% |
96.66% |
Lab G |
| 23 May 2026 |
Ivermectin |
8.3 |
100mg |
96.2mg |
-3.8% |
97.41% |
Lab F |
| 23 May 2026 |
KPV Oral |
9.7 |
50mg |
56.0mg |
+11.9% |
99.81% |
Lab B |
| 23 May 2026 |
Minoxidil Oral |
8.5 |
10mg |
10.1mg |
+1.3% |
96.93% |
Lab B |
| 23 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
9.9 |
20mg |
19.6mg |
-2.1% |
99.05% |
Lab E |
| 23 May 2026 |
PE 22-28 |
7.6 |
2mg |
2.5mg |
+23.3% |
99.94% |
Lab G |
| 23 May 2026 |
Superdrol |
9.1 |
20mg |
20.8mg |
+3.8% |
99.37% |
Lab C |
| 23 May 2026 |
Thymosin Alpha-1 |
9.9 |
10mg |
12.3mg |
+23.4% |
95.81% |
Lab F |
| 22 May 2026 |
Retatrutide |
|
9.4 |
24mg |
23.3mg |
-2.9% |
RT202602 |
| 21 May 2026 |
Tesamorelin |
|
6.7 |
10mg |
12.8mg |
+28.0% |
TES202601 |
| 21 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
7.3 |
200mg/ml |
222.7mg/ml |
+11.3% |
95.89% |
Lab F |
| 21 May 2026 |
HMG |
8.3 |
5mg |
4.4mg |
-11.9% |
95.38% |
Lab A |
| 21 May 2026 |
Tesamorelin |
|
5.3 |
10mg |
12mg |
+20.0% |
TES202601 |
| 21 May 2026 |
DHB (1-Test Cyp) Oral |
6.9 |
20mg |
22.1mg |
+10.4% |
99.69% |
Lab C |
| 21 May 2026 |
KPV |
8.8 |
30mg |
30.3mg |
+1.1% |
95.23% |
Lab F |
| 21 May 2026 |
LGD-4033 (Ligandrol) |
9.4 |
25mg |
28.2mg |
+13.0% |
98.31% |
Lab A |
| 21 May 2026 |
PTD-DBM |
5.6 |
15mg |
18.7mg |
+24.9% |
95.75% |
Lab A |
| 21 May 2026 |
Telmisartan |
8.5 |
50mg |
52.5mg |
+4.9% |
98.23% |
Lab D |
| 20 May 2026 |
Cabergoline |
8.7 |
10mg |
11.6mg |
+16.3% |
98.33% |
Lab C |
| 20 May 2026 |
HMG |
7.9 |
30mg |
33.4mg |
+11.2% |
98.09% |
Lab D |
| 20 May 2026 |
Retatrutide 30mg Pen Kit |
7.9 |
20mg |
20.6mg |
+3.2% |
95.82% |
Lab A |
| 20 May 2026 |
Test Suspension |
8.6 |
250mg/ml |
264.5mg/ml |
+5.8% |
98.71% |
Lab B |
| 20 May 2026 |
Thymosin Alpha-1 |
7.4 |
50mg |
44.3mg |
-11.5% |
96.17% |
Lab A |
| 19 May 2026 |
BPC157 5mg + TB500 5mg Blend |
8.4 |
20mg |
21.9mg |
+9.3% |
99.56% |
Lab C |
| 19 May 2026 |
Cerebrolysin |
7.0 |
20mg |
18.5mg |
-7.5% |
97.85% |
Lab D |
| 19 May 2026 |
MT-1 |
7.9 |
50mg |
57.4mg |
+14.7% |
97.84% |
Lab D |
| 19 May 2026 |
Testosterone Cypionate Raw |
9.4 |
10g |
9.0g |
-9.9% |
99.74% |
Lab D |
| 17 May 2026 |
Drostanolone Enanthate (Mast E) Raw |
7.1 |
5g |
6.2g |
+24.0% |
96.37% |
Lab B |
| 17 May 2026 |
NAD+ |
7.7 |
10mg |
10.0mg |
-0.1% |
96.17% |
Lab C |
| 17 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.2 |
5g |
5.1g |
+2.4% |
97.32% |
Lab C |
| 17 May 2026 |
Superdrol |
9.8 |
10mg |
9.6mg |
-4.0% |
99.69% |
Lab E |
| 17 May 2026 |
Testosterone Cypionate Raw |
9.2 |
500g |
615.9g |
+23.2% |
95.74% |
Lab A |
| 29 Jan 2026 |
Clenbuterol |
8.2 |
100mg |
99.3mg |
-0.7% |
96.68% |
Lab C |
| 29 Jan 2026 |
Retatrutide 30mg Pen Kit |
9.5 |
30mg |
30.7mg |
+2.5% |
96.90% |
Lab D |
| 26 Jan 2026 |
Andarine (S-4) Raw |
5.4 |
1g |
1.0g |
+1.7% |
99.55% |
Lab E |
| 26 Jan 2026 |
Aromasin (Exemestane) |
7.4 |
25mg |
29.8mg |
+19.2% |
95.04% |
Lab B |
| 26 Jan 2026 |
MT-1 |
6.4 |
5mg |
4.8mg |
-4.7% |
99.09% |
Lab A |
| 26 Jan 2026 |
PTD-DBM |
9.8 |
15mg |
18.7mg |
+25.0% |
97.12% |
Lab B |
| 19 Jan 2026 |
Clenbuterol |
9.9 |
100mg |
110.2mg |
+10.2% |
97.92% |
Lab D |
| 19 Jan 2026 |
EPO |
8.1 |
10mg |
10.2mg |
+1.8% |
98.21% |
Lab G |
| 19 Jan 2026 |
KPV |
8.8 |
50mg |
56.0mg |
+12.0% |
99.36% |
Lab C |
| 19 Jan 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.0 |
10g |
12.4g |
+24.2% |
97.86% |
Lab D |
| 19 Jan 2026 |
Thymosin Alpha-1 |
9.7 |
50mg |
45.8mg |
-8.4% |
98.02% |
Lab D |
| 9 Jan 2026 |
Cartalax |
9.2 |
10mg |
8.8mg |
-12.1% |
96.72% |
Lab E |
| 9 Jan 2026 |
Drostanolone Enanthate (Mast E) Raw |
9.1 |
100g |
92.2g |
-7.8% |
99.77% |
Lab F |
| 9 Jan 2026 |
EPO |
8.3 |
50mg |
55.6mg |
+11.1% |
96.02% |
Lab C |
| 9 Jan 2026 |
Ivermectin |
10.0 |
100mg |
87.1mg |
-12.9% |
98.53% |
Lab D |
| 9 Jan 2026 |
KPV |
8.6 |
30mg |
36.9mg |
+23.0% |
95.60% |
Lab A |
| 9 Jan 2026 |
Lipo-C FAT BLASTER |
9.1 |
300mg/ml |
260.4mg/ml |
-13.2% |
97.34% |
Lab C |
| 9 Jan 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
10.0 |
5mg |
5.8mg |
+15.7% |
95.56% |
Lab F |
| 9 Jan 2026 |
PTD-DBM |
8.2 |
30mg |
32.5mg |
+8.3% |
99.58% |
Lab D |
| 9 Jan 2026 |
Telmisartan |
10.0 |
100mg |
102.6mg |
+2.6% |
97.42% |
Lab G |
| 7 Jan 2026 |
Drostanolone Enanthate (Mast E) Raw |
9.2 |
500g |
477.3g |
-4.5% |
97.12% |
Lab G |
| 7 Jan 2026 |
EPO |
9.0 |
30mg |
29.2mg |
-2.7% |
97.66% |
Lab E |
| 7 Jan 2026 |
Lipo-C FAT BLASTER |
6.2 |
100mg/ml |
111.4mg/ml |
+11.4% |
95.51% |
Lab D |
| 6 Jan 2026 |
DNP |
7.1 |
50mg |
52.8mg |
+5.7% |
97.99% |
Lab B |
| 6 Jan 2026 |
DNP |
7.8 |
10mg |
10.9mg |
+8.8% |
95.52% |
Lab C |
| 6 Jan 2026 |
Ivermectin |
9.1 |
10mg |
9.9mg |
-0.8% |
97.47% |
Lab D |
| 6 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
8.9 |
20mg |
23.1mg |
+15.3% |
97.30% |
Lab F |
| 6 Jan 2026 |
PTD-DBM |
6.6 |
10mg |
10.2mg |
+1.8% |
97.42% |
Lab F |
| 29 Dec 2025 |
Cartalax |
10.0 |
5mg |
5.0mg |
+0.8% |
99.11% |
Lab F |
| 29 Dec 2025 |
Minoxidil Oral |
8.1 |
100mg |
103.1mg |
+3.1% |
99.24% |
Lab E |
| 29 Dec 2025 |
Superdrol |
9.9 |
25mg |
25.3mg |
+1.3% |
95.36% |
Lab C |
| 12 Dec 2025 |
Andarine (S-4) Raw |
6.4 |
100g |
98.1g |
-1.9% |
95.15% |
Lab E |
| 12 Dec 2025 |
HMG |
9.7 |
5mg |
5.1mg |
+3.0% |
96.75% |
Lab G |
| 12 Dec 2025 |
KPV |
9.1 |
50mg |
58.6mg |
+17.2% |
96.37% |
Lab D |
| 12 Dec 2025 |
Minoxidil Oral |
8.7 |
100mg |
120.6mg |
+20.6% |
97.13% |
Lab G |
| 12 Dec 2025 |
Thymosin Alpha-1 |
8.1 |
5mg |
4.4mg |
-11.9% |
97.80% |
Lab F |
| 5 Dec 2025 |
Blend 300 (TRA/Mast P/Test P) |
6.6 |
250mg/ml |
243.4mg/ml |
-2.7% |
97.58% |
Lab B |
| 5 Dec 2025 |
Cabergoline |
8.2 |
100mg |
106.8mg |
+6.8% |
97.68% |
Lab C |
| 5 Dec 2025 |
Cerebrolysin |
9.1 |
15mg |
14.8mg |
-1.4% |
95.80% |
Lab C |
| 23 Nov 2025 |
ARA-290 |
8.0 |
30mg |
32.8mg |
+9.3% |
95.71% |
Lab A |
| 23 Nov 2025 |
Blend 300 (TRA/Mast P/Test P) |
9.9 |
250mg/ml |
280.8mg/ml |
+12.3% |
95.59% |
Lab C |
| 23 Nov 2025 |
Drostanolone Enanthate (Mast E) Raw |
10.0 |
1g |
1.1g |
+5.6% |
97.73% |
Lab C |
| 23 Nov 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
8.0 |
100g |
111.8g |
+11.8% |
97.38% |
Lab C |
| 23 Nov 2025 |
Retatrutide 30mg Pen Kit |
6.3 |
20mg |
22.8mg |
+14.1% |
95.39% |
Lab B |
| 23 Nov 2025 |
Superdrol |
9.2 |
25mg |
29.8mg |
+19.1% |
98.82% |
Lab E |
| 17 Nov 2025 |
Cerebrolysin |
7.2 |
20mg |
21.5mg |
+7.4% |
98.66% |
Lab C |
| 17 Nov 2025 |
Clomid |
8.3 |
20mg |
23.1mg |
+15.6% |
96.86% |
Lab C |
| 17 Nov 2025 |
DNP |
6.8 |
100mg |
108.0mg |
+8.0% |
97.58% |
Lab F |
| 17 Nov 2025 |
EPO |
7.4 |
5mg |
4.4mg |
-11.8% |
99.96% |
Lab E |
| 17 Nov 2025 |
Hexarelin |
8.8 |
20mg |
22.7mg |
+13.7% |
95.97% |
Lab D |
| 17 Nov 2025 |
Hexarelin |
8.8 |
10mg |
9.3mg |
-6.7% |
95.13% |
Lab E |
| 17 Nov 2025 |
Lipo-C FAT BLASTER |
6.4 |
100mg/ml |
92.6mg/ml |
-7.4% |
98.73% |
Lab A |
| 17 Nov 2025 |
PE 22-28 |
9.9 |
10mg |
8.9mg |
-11.0% |
95.79% |
Lab E |
| 17 Nov 2025 |
Tesofensine |
8.7 |
10mg |
9.4mg |
-5.6% |
95.73% |
Lab C |
| 14 Nov 2025 |
Cabergoline |
7.8 |
20mg |
21.3mg |
+6.5% |
99.24% |
Lab D |
| 14 Nov 2025 |
Cabergoline |
6.9 |
25mg |
26.8mg |
+7.4% |
96.41% |
Lab G |
| 14 Nov 2025 |
DNP |
8.1 |
50mg |
48.5mg |
-3.1% |
97.09% |
Lab C |
| 14 Nov 2025 |
Primobolan Oral (Methenolone Acetate) |
8.1 |
100mg |
89.9mg |
-10.1% |
96.31% |
Lab D |
| 14 Nov 2025 |
PTD-DBM |
7.6 |
20mg |
22.7mg |
+13.5% |
98.72% |
Lab G |
| 14 Nov 2025 |
Superdrol |
7.2 |
25mg |
26.9mg |
+7.7% |
97.05% |
Lab F |
| 5 Nov 2025 |
Aromasin (Exemestane) |
10.0 |
100mg |
102.7mg |
+2.7% |
96.41% |
Lab C |
| 5 Nov 2025 |
Hexarelin |
6.0 |
50mg |
50.4mg |
+0.7% |
96.65% |
Lab B |
| 5 Nov 2025 |
Ivermectin |
6.6 |
50mg |
59.0mg |
+18.0% |
97.12% |
Lab B |
| 5 Nov 2025 |
Ivermectin |
10.0 |
10mg |
9.9mg |
-1.0% |
99.05% |
Lab C |
| 5 Nov 2025 |
Minoxidil Oral |
9.9 |
100mg |
103.9mg |
+3.9% |
95.16% |
Lab E |
| 4 Nov 2025 |
Clomid |
8.7 |
20mg |
23.2mg |
+16.2% |
98.45% |
Lab E |
| 4 Nov 2025 |
KPV Oral |
9.6 |
20mg |
20.7mg |
+3.3% |
97.17% |
Lab G |
| 4 Nov 2025 |
KPV |
7.3 |
2mg |
2.1mg |
+2.5% |
99.45% |
Lab D |
| 4 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
9.2 |
2mg |
2.0mg |
+1.5% |
98.86% |
Lab D |
| 17 Oct 2025 |
Cabergoline |
9.7 |
10mg |
10.9mg |
+8.9% |
95.99% |
Lab A |
| 17 Oct 2025 |
KPV Oral |
9.1 |
100mg |
120.8mg |
+20.8% |
96.13% |
Lab D |
| 17 Oct 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
7.4 |
5mg |
5.2mg |
+4.6% |
97.32% |
Lab A |
| 17 Oct 2025 |
Testosterone Cypionate Raw |
8.3 |
100g |
91.6g |
-8.4% |
95.70% |
Lab E |
| 17 Oct 2025 |
Thymosin Alpha-1 |
6.9 |
2mg |
1.7mg |
-13.3% |
98.71% |
Lab G |
| 9 Oct 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
8.3 |
10g |
9.7g |
-2.9% |
96.90% |
Lab G |
| 9 Oct 2025 |
Superdrol |
10.0 |
50mg |
52.0mg |
+4.0% |
98.61% |
Lab F |
| 9 Oct 2025 |
Test Suspension |
10.0 |
200mg/ml |
195.7mg/ml |
-2.1% |
96.37% |
Lab G |
| 3 Oct 2025 |
ARA-290 |
7.4 |
50mg |
57.8mg |
+15.5% |
95.20% |
Lab F |
| 3 Oct 2025 |
HMG |
5.2 |
20mg |
19.7mg |
-1.7% |
96.09% |
Lab F |
| 3 Oct 2025 |
Lipo-C FAT BLASTER |
4.6 |
100mg/ml |
105.7mg/ml |
+5.7% |
95.66% |
Lab E |
| 3 Oct 2025 |
Primobolan Oral (Methenolone Acetate) |
5.7 |
25mg |
21.3mg |
-15.0% |
95.94% |
Lab G |
| 3 Oct 2025 |
Primobolan Oral (Methenolone Acetate) |
8.3 |
100mg |
95.1mg |
-4.9% |
98.31% |
Lab F |
| 3 Oct 2025 |
Testosterone Cypionate Raw |
8.2 |
10g |
9.8g |
-1.5% |
96.95% |
Lab A |